MassDevice.com +5 | The top 5 medtech stories for August 2, 2016

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Alcyone Lifesciences seeks FDA nod for ReFlow neuro cath Alcyone Lifesciences is seeking formal commercial approval for its device to treat fluid buildup in the brain, following its successful implant in 4 patients in an ongoing study at Boston Children’s Hospital. The Lowell, Mass.-based company said that its decision to file a 510(k) premarket notification with the FDA seeking a regulatory sign-off for its ReFlow System also comes after the successful completion of a number of bench and animal studies. Read more 4. Boston Scientific issues urgent field safety notice for select Lotus valves Boston Scientific this week issued a voluntary field safety corrective action for its Lotus Valve Systems, looking to recall units from the field over issues with release mandrel breakage. The company is looking to “remove units from the field” that were manufactured prior to a component related change made in March this year, and specified that units manufactured after the change was implemented are not affected. Read more 3. Glaukos raises guidance after Street-beating Q...
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 5 Source Type: news